I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 22% ± 6% | |
| epithelial cell | 5 studies | 30% ± 13% | |
| macrophage | 5 studies | 17% ± 2% | |
| GABAergic neuron | 4 studies | 31% ± 14% | |
| glutamatergic neuron | 4 studies | 36% ± 16% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 2% | |
| classical monocyte | 3 studies | 22% ± 4% | |
| conventional dendritic cell | 3 studies | 30% ± 11% | |
| non-classical monocyte | 3 studies | 26% ± 7% | |
| fibroblast | 3 studies | 25% ± 5% | |
| astrocyte | 3 studies | 23% ± 5% | |
| dendritic cell | 3 studies | 34% ± 7% | |
| natural killer cell | 3 studies | 19% ± 3% | |
| basal cell | 3 studies | 25% ± 9% | |
| interneuron | 3 studies | 26% ± 14% | |
| neuron | 3 studies | 24% ± 6% | |
| oligodendrocyte | 3 studies | 16% ± 1% |
